Nath Bio-Genes (India) Limited

Agricultural Inputs
Basic Materials

Prices are adjusted according to historical splits.

Nath Bio-Genes (India) Limited Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
₹4.00 billion
Book Value:
Revenue TTM:
₹3.27 billion
Operating Margin TTM:
Gross Profit TTM:
₹1.67 billion
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Nath Bio-Genes (India) Limited had its IPO on under the ticker symbol NATHBIOGEN.

The company operates in the Basic Materials sector and Agricultural Inputs industry. Nath Bio-Genes (India) Limited has a staff strength of 433 employees.

Stock update

Shares of Nath Bio-Genes (India) Limited opened at ₹227.35 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹210.55 - ₹227.35, and closed at ₹212.9.

This is a -5.84% slip from the previous day's closing price.

A total volume of 23,020 shares were traded at the close of the day’s session.

In the last one week, shares of Nath Bio-Genes (India) Limited have increased by +2.26%.

Nath Bio-Genes (India) Limited's Key Ratios

Nath Bio-Genes (India) Limited has a market cap of ₹4.00 billion, indicating a price to book ratio of 0.5917 and a price to sales ratio of 1.2055.

In the last 12-months Nath Bio-Genes (India) Limited’s revenue was ₹3.27 billion with a gross profit of ₹1.67 billion and an EBITDA of ₹509.54 million. The EBITDA ratio measures Nath Bio-Genes (India) Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nath Bio-Genes (India) Limited’s operating margin was 14.67% while its return on assets stood at 3.73% with a return of equity of 6.28%.

In Q2, Nath Bio-Genes (India) Limited’s quarterly earnings growth was a positive 8% while revenue growth was a positive 12.4%.

Nath Bio-Genes (India) Limited’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at ₹19.78 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nath Bio-Genes (India) Limited’s profitability.

Nath Bio-Genes (India) Limited stock is trading at a EV to sales ratio of 1.617 and a EV to EBITDA ratio of -7.0646. Its price to sales ratio in the trailing 12-months stood at 1.2055.

Nath Bio-Genes (India) Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 89.33%.

Balance sheet and cash flow metrics

Total Assets
₹7.93 billion
Total Liabilities
₹2.16 billion
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Nath Bio-Genes (India) Limited ended 2024 with ₹7.93 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹7.93 billion while shareholder equity stood at ₹5.73 billion.

Nath Bio-Genes (India) Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹2.16 billion in other current liabilities, in common stock, ₹4.06 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹379.95 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹4.03 million.

Nath Bio-Genes (India) Limited’s total current assets stands at ₹5.21 billion while long-term investments were ₹0 and short-term investments were ₹1.71 billion. Its net receivables were ₹973.14 million compared to accounts payable of ₹277.36 million and inventory worth ₹2.08 billion.

In 2024, Nath Bio-Genes (India) Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Nath Bio-Genes (India) Limited paid ₹0.89 in dividends in 2024.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Nath Bio-Genes (India) Limited stock is currently trading at ₹212.9 per share. It touched a 52-week high of ₹243.7 and a 52-week low of ₹243.7. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹215.56 and 200-day moving average was ₹172.93 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6165% of the company’s stock are held by insiders while 460.8% are held by institutions.

Frequently Asked Questions About Nath Bio-Genes (India) Limited

The stock symbol (also called stock or share ticker) of Nath Bio-Genes (India) Limited is NATHBIOGEN

The IPO of Nath Bio-Genes (India) Limited took place on

Similar Industry Stocks (Agricultural Inputs)

Last Price
Music Broadcast Ltd (RADIOCITY)

Most Active

Last Price
Amyris Inc (AMRS)
Humbl Inc (HMBL)

Top Gainers

Last Price
Latch Inc (LTCHW)

Top Losers

Last Price


Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green peas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win Chi Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. The company offers its products through a network of distributors, dealers, branch offices, conditioned warehouses, and processing plants. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.